Combination treatment with oHSV and Trametinib enhanced virus replication mediated by down-regulation of STAT1 and PKR expression or phosphorylation in BRAF V600E-mutated tumor cells as well as BRAF wt/KRAS-mutated tumor cells (3). This evidence concerns the gene BRAF and neoplasm.